000 01593 a2200481 4500
005 20250512113558.0
264 0 _c19721012
008 197210s 0 0 eng d
022 _a0009-9236
024 7 _a10.1002/cpt1972135part1671
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeiss, J L
245 0 0 _aCardiovascular effects of delta-9-tetrahydrocannabinol in man.
_h[electronic resource]
260 _bClinical pharmacology and therapeutics
_c
300 _a671-84 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aBehavior
_xdrug effects
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aCannabis
_xpharmacology
650 0 4 _aCarbon Isotopes
650 0 4 _aClinical Trials as Topic
650 0 4 _aDronabinol
_xadministration & dosage
650 0 4 _aElectrocardiography
650 0 4 _aEpinephrine
_xurine
650 0 4 _aForearm
_xblood supply
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHemodynamics
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNorepinephrine
_xurine
650 0 4 _aPosture
650 0 4 _aPsychological Tests
650 0 4 _aRegional Blood Flow
_xdrug effects
650 0 4 _aVascular Resistance
_xdrug effects
700 1 _aWatanabe, A M
700 1 _aLemberger, L
700 1 _aTamarkin, N R
700 1 _aCardon, P V
773 0 _tClinical pharmacology and therapeutics
_gvol. 13
_gno. 5
_gp. 671-84
856 4 0 _uhttps://doi.org/10.1002/cpt1972135part1671
_zAvailable from publisher's website
999 _c4563936
_d4563936